Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA let-7c is a non-coding RNA and member of the highly conserved let-7 family of microRNAs, originally discovered for its role in developmental timing. In humans, let-7c acts as a post-transcriptional regulator by binding to the 3’ untranslated regions of target mRNAs, repressing genes involved in cell proliferation and differentiation such as MYC, RAS, and CDC25A. Let-7c is widely recognized as a tumor suppressor, commonly downregulated in various cancers including prostate cancer and hepatocellular carcinoma, where its restoration inhibits tumor cell proliferation, induces apoptosis, and suppresses tumor growth in vivo. Let-7c also plays key roles in neural differentiation and is implicated in disease processes beyond cancer, including as a biomarker and potential therapeutic target[1][2][4][5][6][12][13].
Silencing of target oncogenes (e.g., MYC, RAS, AR, CDC25A) via mRNA degradation or translational repression[1][2][4][12]. Negative feedback on Lin28/let-7c axis[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA let-7c (MIRLET7C).